Hrt Financial LP Corcept Therapeutics Inc Transaction History

Hrt Financial LP

$17.7 Billion
Q2 2025

A detailed history of Hrt Financial LP transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Hrt Financial LP holds 200,996 shares of CORT stock, worth $14.8 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

200,996

Holding current value

$14.8 Million

% of portfolio

0.08%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$62.24 - $91.93 $12.5 Million - $18.5 Million	200,996 New	200,996 $14.8 Million
Q4 2024 Feb 14, 2025	BUY	$44.66 - $60.85 $240,494 - $327,677	5,385 New	5,385 $271,000
Q1 2024 May 13, 2024	SELL	$21.1 - $27.46 $821,718 - $1.07 Million	-38,944 Reduced 65.09%	20,890 $526,000
Q4 2023 Feb 09, 2024	BUY	$24.82 - $32.88 $689,425 - $913,307	27,777 Added 86.65%	59,834 $1.94 Million
Q3 2023 Nov 13, 2023	SELL	$21.97 - $33.8 $1.67 Million - $2.58 Million	-76,185 Reduced 70.38%	32,057 $873,000
Q2 2023 Aug 11, 2023	BUY	$21.44 - $25.15 $2.1 Million - $2.46 Million	97,741 Added 930.78%	108,242 $2.41 Million
Q1 2023 May 12, 2023	SELL	$19.2 - $24.47 $2.28 Million - $2.9 Million	-118,509 Reduced 91.86%	10,501 $227,000
Q4 2022 Feb 10, 2023	BUY	$19.95 - $29.96 $2.38 Million - $3.57 Million	119,319 Added 1231.24%	129,010 $2.62 Million
Q3 2022 Nov 14, 2022	SELL	$24.7 - $29.12 $1.26 Million - $1.48 Million	-50,883 Reduced 84.0%	9,691 $248,000
Q2 2022 Aug 12, 2022	SELL	$17.33 - $25.3 $744,046 - $1.09 Million	-42,934 Reduced 41.48%	60,574 $1.44 Million
Q1 2022 May 16, 2022	SELL	$16.53 - $25.21 $704,095 - $1.07 Million	-42,595 Reduced 29.15%	103,508 $2.33 Million
Q4 2021 Feb 14, 2022	BUY	$17.1 - $23.34 $1.55 Million - $2.11 Million	90,461 Added 162.58%	146,103 $2.89 Million
Q3 2021 Nov 15, 2021	BUY	$19.68 - $22.53 $556,314 - $636,878	28,268 Added 103.27%	55,642 $1.1 Million
Q2 2021 Aug 16, 2021	BUY	$19.97 - $24.43 $344,502 - $421,441	17,251 Added 170.41%	27,374 $602,000
Q1 2021 May 17, 2021	BUY	$23.49 - $30.56 $237,789 - $309,358	10,123 New	10,123 $240,000
Q4 2019 Feb 14, 2020	SELL	$12.06 - $16.96 $261,099 - $367,184	-21,650 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$10.41 - $14.66 $225,376 - $317,389	21,650 New	21,650 $306,000

Others Institutions Holding CORT

# of Institutions

479

Shares Held

83.4M

Call Options Held

489K

Put Options Held

1.02M

View Full List

About CORCEPT THERAPEUTICS INC

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $7.87B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

More about CORT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.

Account